Evaluating cost-effectiveness in the management of neuroendocrine neoplasms

White, BE, Mujica-Mota, R orcid.org/0000-0002-7430-2744, Snowsill, T et al. (3 more authors) (2020) Evaluating cost-effectiveness in the management of neuroendocrine neoplasms. Reviews in Endocrine and Metabolic Disorders. ISSN 1389-9155



Copyright, Publisher and Additional Information: © The Author(s) 2020. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Keywords: Neuroendocrine neoplasia . Health economic evaluation . Neuroendocrine tumour . Carcinoid tumour . Carcinoid syndrome
  • Accepted: 14 October 2020
  • Published (online): 6 November 2020
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Health Sciences (Leeds) > Academic Unit of Health Economics (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 26 Nov 2020 14:44
Last Modified: 26 Nov 2020 14:44
Status: Published online
Publisher: Springer
Identification Number: https://doi.org/10.1007/s11154-020-09608-y

Share / Export